Last updated on January 2019

A Trial of Linaclotide 290 g in Patients With Irritable Bowel Syndrome With Constipation

Brief description of study

To evaluate the efficacy on abdominal symptoms (abdominal bloating, abdominal discomfort, and abdominal pain) and safety of linaclotide 290 g administered orally to patients with irritable bowel syndrome with constipation (IBS-C).

Detailed Study Description

12 week treatment period followed by 4-week Randomized Withdrawal (RW) Period.

Clinical Study Identifier: NCT03573908

Contact Investigators or Research Sites near you

Start Over

Partners In Clinical Research

Cumberland, RI United States

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.